en

PRODUCT DETAIL

Febuxostát MSN 80 mg filmom obalené tablety

Code 2252D
MA number 29/0244/19-S
Product Form: tbl flm 28x80 mg (blis.Alcar/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
ATC:
M MUSCULO-SKELETAL SYSTEM
M04 ANTIGOUT PREPARATIONS
M04A ANTIGOUT PREPARATIONS
M04AA Preparations inhibiting uric acid production
M04AA03 Febuxostat
Shelf life: 36
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 06.08.2019
Validity: 06.08.2024
SPC: SPC_Febuxostát MSN 80 mg filmom obalené tablety_08.2022.pdf  
PIL: PIL_Febuxostát MSN filmom obalené tablety_08.2022.pdf  
Safety feature Yes
Data update: 06.08.2019
eu-flag.png sk-flag.png